1. Introduction {#sec1-pathogens-06-00012}
===============

Equine protozoal myeloencephalitis (EPM) is an infectious, progressive, degenerative neurological disease of horses caused by the apicomplexan parasite, *Sarcocystis neurona* \[[@B1-pathogens-06-00012]\]. To complete its life cycle, this heteroxenous parasite requires a reservoir host (i.e., opossums; *Didelphis virginiana*, *Didelphis albiventris*) and an aberrant (horses) or intermediate host (cats, skunks, raccoons and sea otters) \[[@B2-pathogens-06-00012]\]. Opossums become infected upon ingestion of sarcocysts containing hundreds of bradyzoites. The bradyzoites undergo gametogony and sporulate into mature oocysts that are then shed in the feces. After ingestion by the intermediate or aberrant hosts, the oocysts transform into the environmentally-resistant sporozoites that chronically parasitize the neural and inflammatory cells of the host's central nervous system (CNS). Clinical EPM symptoms depend on the part of the CNS that is parasitized and in general results in abnormal gait, dysphagia and muscle atrophy in affected horses \[[@B3-pathogens-06-00012]\].

The intracellular nature of *S. neurona* and its ability to evade the host's immune surveillance \[[@B4-pathogens-06-00012]\] makes EPM treatment expensive, lengthy and challenging. Traditionally, clinical treatment of EPM involved inhibitors of folate synthesis and metabolism (sulfonamides/pyrimethamine combination) over a prolonged period \[[@B5-pathogens-06-00012]\]. More recently, triazines derivatives (diclazuril, ponazuril) that target the parasite's apicoplast \[[@B6-pathogens-06-00012]\], nitazoxanide, a pyruvate:ferredoxin oxidoreductase analogue that inhibits the parasite's anaerobic metabolism \[[@B7-pathogens-06-00012]\], and anti-inflammatory agents and immune stimulants \[[@B8-pathogens-06-00012]\] have been used with variable success in eliminating clinical signs. Despite the availability of these drugs, EPM treatment is complicated by the emergence of drug-resistance (due to intermittent or periodic treatments), cost of therapies and drug toxicity and infection relapses due to re-growth of residual parasites after the treatment regimes \[[@B2-pathogens-06-00012]\]. As such, the discovery and development of novel therapeutics for EPM is imperative.

To successfully invade the host cells, apicomplexans utilize three specialized exocytic organelles (micronemes, rhoptries and dense-granules) \[[@B9-pathogens-06-00012]\]. The microneme is used for host cell recognition, binding, penetration and gliding along the cytoskeletal structures. Rhoptry proteins are discharged into the host cell during parasite internalization and are crucial in the formation of the parasitophorous vacuoles (PVs). Developing zoites contain non-pedunculated condensing vesicles that synthesize and package inactive rhoptry proteins, which are proteolytically activated when the rhoptry contents are condensed \[[@B10-pathogens-06-00012]\]. The PVs facilitate parasite development by allowing nutrient transport from the host cell and by blocking lysosomal fusion, which would otherwise kill the parasites \[[@B11-pathogens-06-00012]\]. Upon internalization, zoites use the dense-granules to remodel the PVs into functionally-active organelles.

The proliferation and differentiation of apicomplexans are influenced by protein kinases (PKs) that are involved in the invasion and modification of host cell structure and function. Generally, PKs can be classified into the conventional ("typical") eukaryotic PK (ePK) and "atypical" PK (aPK) superfamilies \[[@B12-pathogens-06-00012],[@B13-pathogens-06-00012],[@B14-pathogens-06-00012]\]. Based on the controlled vocabulary of Hanks et al.'s \[[@B12-pathogens-06-00012],[@B15-pathogens-06-00012]\] classification scheme, there are eight ePK families. These include PKs A, G and C (AGCs), calmodulin/calcium-dependent PKs (CAMKs), CMGC (including cyclin-dependent kinases (CDKs), mitogen-activated protein kinases (MAP kinases), glycogen synthase kinases (GSK) and CDK-like kinases), casein kinase 1 (CK1), "sterile-phenotype" kinases (STEs), receptor guanylate cyclase (RGC), tyrosine kinases (TKs), tyrosine kinase-like kinases (TKLs) and the "other PKs" sub-family (OPKs) \[[@B16-pathogens-06-00012]\]. The aPK superfamily consist of the Alpha-kinases, pyruvate dehydrogenase kinases (PDHK), phosphatidylinositol 3-kinase-related kinases (PIKK) and right open reading frame (RIO) kinases \[[@B17-pathogens-06-00012]\]. Although generally lacking or having limited sequence similarity to the ePKs and constituting small families in all organisms, some aPKs are homologous to catalytically-active PKs \[[@B12-pathogens-06-00012]\].

Several kinomes have been characterized in various organisms \[[@B14-pathogens-06-00012]\], including yeast, fruit fly, roundworms and human \[[@B18-pathogens-06-00012]\]. In Apicomplexans, the kinome of the malaria parasite, *Plasmodium falciparum*, was initially reported to contain 85 typical ePKs, which clustered into several groups including five of the major ePKs (i.e., CK1, TKL, CMGC, CAMK and AGC), but was devoid of STEs and TKs \[[@B18-pathogens-06-00012]\]. Subsequent studies on the *Plasmodium* kinome resulted in the identification of more PKs and PK-like proteins, adding up to 99 PKs \[[@B19-pathogens-06-00012],[@B20-pathogens-06-00012]\]. However, despite the diverse repertoire of the *Plasmodium* ePKs, reverse genetics studies revealed that over 30% of the kinases are nonessential for the parasite's asexual blood-stage development; only three of the 12 ePKs required for *Plasmodium* transmission in vivo have been conclusively demonstrated to be essential for the parasite's asexual development \[[@B21-pathogens-06-00012]\]. Kinomes of a dozen other apicomplexan species have been reported, notable of which are *Toxoplasma*, *Cryptosporidium* and *Babesia* species \[[@B17-pathogens-06-00012]\]. Talevich et al. \[[@B22-pathogens-06-00012]\] recently classified ePKs into 17 genomes in Apicomplexa (*Coccidia*, *Piroplasmida* and *Haemosporida* species). The Rhoptry kinases (ROPKs) and pseudokinases in some coccidian genomes (*Toxoplasma gondii*, *Neospora caninum*, *Eimeria tenella* and portions of *S. neurona*) have been recently catalogued into 42 subfamilies \[[@B23-pathogens-06-00012]\]. Overall, at least 65 orthologous PK groups amongst the 12 kinomes described in the apicomplexans are shared with other alveolates and/or metazoans \[[@B17-pathogens-06-00012],[@B24-pathogens-06-00012]\].

Each of the PK families has vital roles in parasite's survival. For instance, PfPK-B (AGC family), PfTKL3 (TKL family) and four of the seven CDPKs (CAMK family) are required by *Plasmodium* parasites to complete their asexual cycle \[[@B25-pathogens-06-00012],[@B26-pathogens-06-00012],[@B27-pathogens-06-00012]\]. In a recent study, deletion of TgCK1α (CK1 family) resulted in defective replication of *T. gondii* in vitro \[[@B28-pathogens-06-00012]\]. The *P. falciparum* CKL and SRPK1 (CMGC family) complement each other in the regulation of mRNA splicing \[[@B29-pathogens-06-00012]\]. Since apicomplexans lack typical MAPK cascades, the STEs are not well studied. However, in the parasites that do have the MAPK pathways, STEs are essential for parasite growth (e.g., in the human parasites, *Schistosoma mansoni* \[[@B30-pathogens-06-00012]\]). Further, for parasites without the conventional MAPK cascades, PKs may activate the signaling pathways, for instance the *Plasmodium* Pfnek-1/3 \[[@B31-pathogens-06-00012],[@B32-pathogens-06-00012]\]. It should however be noted that the activation of *Plasmodium* MAPK via Pfnek-1/3-mediated phosphorylation has only been demonstrated in vitro; there is no sufficient evidence of MAPK signaling in vivo in the parasite. Finally, some of the notable OPKs include aurora kinases, rhoptry kinases (ROPKs) and parasite-specific eukaryotic initiation factor-2 (elF2) kinases (elF2K), which are important in parasite virulence and differentiation \[[@B23-pathogens-06-00012],[@B33-pathogens-06-00012],[@B34-pathogens-06-00012]\].

Here, we used a genome-wide approach to define the kinome of *S. neurona* and determined the relatedness of the putative PKs to those reported in other apicomplexans. Defining the *S. neurona* kinome is not only important in providing insights into the parasite biology, but also identification of potential novel drug targets that can be used to clear chronic *S. neurona* infections and reduce parasite survival.

2. Results {#sec2-pathogens-06-00012}
==========

2.1. Sarcocystis neurona Encodes 97 Putative Kinases {#sec2dot1-pathogens-06-00012}
----------------------------------------------------

To date, at least 15 apicomplexan genomes (coccidians, gregarines, hemosporidians and piroplasmids) have either been fully sequenced or partially annotated \[[@B24-pathogens-06-00012]\]. In the current study, we conducted an exhaustive genome-wide search of the newly-sequenced *S. neurona* genome \[[@B35-pathogens-06-00012]\], and identified 97 putative PKs ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). The identified PKs contained the characteristic PK (IPR000719) or PK-like (IPR011009) domains and three conserved amino acids constituting the catalytic triad (Lys30, Asp125, Asp143). The PKs had sizes ranging between 152 and 6544 amino acids and relative molecular weights of between 15.94 and 671.51 kDa. The majority of the PKs had an isoelectric point (pI) greater than 7.0, implying that the PKs have low turnover rates, since in general, acidic proteins are thought to be degraded more rapidly than neutral or basic proteins \[[@B36-pathogens-06-00012]\].

Assignment of *S. neurona* PK groups was accomplished by sequence clustering using Blast2GO \[[@B37-pathogens-06-00012]\] and by BLASTp searches in the Kinase database \[[@B14-pathogens-06-00012]\]. Out of the eleven known PK groups \[[@B12-pathogens-06-00012],[@B13-pathogens-06-00012],[@B14-pathogens-06-00012]\], *S. neurona* PKs segregated into the AGC (*n* = 9), CAMK (*n* = 20), CK1 (*n* = 3), CMGC (*n* = 19), STE (*n* = 2), TKL (*n* = 6), aPK (*n* = 7) and OPK (*n* = 31) ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). Apart from the 31 OPKs that do not fit into the major kinase groups, the CAMK and CMGC groups, whose members are essential for the parasite's host cell invasion \[[@B38-pathogens-06-00012]\] and differentiation (via cell-cycle regulation) \[[@B39-pathogens-06-00012]\], respectively, had the highest number of PKs, underlying the importance of these processes in the parasite. Unlike in some parasites, such as *P. falciparum* that lack STEs \[[@B18-pathogens-06-00012]\], *S. neurona* contains STE PKs.

### 2.1.1. The AGC Group {#sec2dot1dot1-pathogens-06-00012}

The numbers of apicomplexan AGCs range from four (in *Babesia bovis*) to 15 (in *T. gondii*) \[[@B17-pathogens-06-00012]\]. Based on our Blast2GO annotations and BLASTp homology searches against the kinome database, five out of the nine *S. neurona* AGCs (SRCN_3339, SRCN_3990, SRCN_5165, SRCN_5610 and SRCN_1312) were homologs to the universally-conserved PKAs that are found in *N. caninum* and *T. gondii* (see [Table 1](#pathogens-06-00012-t001){ref-type="table"}). The PKAs are essential for the completion of schizogony (asexual reproduction) in *Plasmodium* parasites \[[@B40-pathogens-06-00012]\]. Further, *S. neurona* contains a putative PKG (SRCN_4518), which shows high homology (92%) to the *T. gondii* TgPKG1 ([Table 1](#pathogens-06-00012-t001){ref-type="table"}); PKGs are essential in apicomplexans \[[@B41-pathogens-06-00012]\].

### 2.1.2. The CAMK Group {#sec2dot1dot2-pathogens-06-00012}

CAMKs form the second-largest apicomplexan PKs (after OPKs). Apicomplexan kinomes constitute varying numbers of CAMKs, which range from seven (in *B. bovis*) to 29 (in *T. gondii*) \[[@B17-pathogens-06-00012]\]. The most important CAMK family is the CDPK, which appeared to constitute almost 50% of *S. neurona* putative CAMKs (see [Table 1](#pathogens-06-00012-t001){ref-type="table"}). In terms of homologies, the *S. neurona* kinome contained orthologs to the *T. gondii* CDPK1 (SCRN_3314), CDPK2B (SCRN_2165), CDPK3 (SCRN_3701), CDPK4 (SCRN_6606), CDPK5 (SCRN_3583), CDPK6 (SCRN_3011), CDPK7 (SCRN_6597) and CDPK8 (SCRN_5948). Other CDPK orthologs were to the *N. caninum* CDPK2 (SCRN_4390) and *Hammondia hammondi* CDPK9 (SCRN_5812) ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). Inhibition of TgCDPK1 has been shown to disrupt the motility, host cell invasion and egress of *T. gondii* \[[@B43-pathogens-06-00012]\]. Owing to the absence of mammalian CDPK homologs, the identification of a relatively large number of CDPK homologs in *S. neurona* could be utilized in the rational design of anti-parasitic therapeutics.

### 2.1.3. The CK1 Group {#sec2dot1dot3-pathogens-06-00012}

It is notable that *S. neurona* putatively encodes for three CK1 enzymes. Apart from *T. gondii* and some alveolates (e.g., *Cryptosporidium hominis* and *Cryptosporidium parvum*, important causative agents of diarrhea in children), which have three and two CK1 enzymes, respectively, most apicomplexans possess a single CK1 enzyme \[[@B17-pathogens-06-00012]\]. Two of the three *S. neurona* putative CK1 (SRCN_3445 and SRCN_4645) showed high sequence similarity (\>90%) to the *T. gondii* TME49_040640 (TgCK1-α) and TGME49_089320 (TgCK1-β), respectively ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). Inhibition of CK1 showed potential for anti-parasitic interventions in *T. gondii* \[[@B44-pathogens-06-00012]\]. CK1 is critical for the asexual proliferation of the *Plasmodium* parasites and is expressed in all of the life-cycle stages of the parasite \[[@B45-pathogens-06-00012]\]. Three putative *S. neurona* CK1 had significant sequence similarity to the *P. falciparum* PfCK1, i.e., 74% (SRCN_3445), 65% (SRCN_4587) and 56% (SRCN_4645) (data not shown).

### 2.1.4. The CMGC Group {#sec2dot1dot4-pathogens-06-00012}

The CMGC is the largest PK group in apicomplexans; CMGC numbers range from 15 in *B. bovis* to 23 in *Plasmodium vivax* \[[@B17-pathogens-06-00012]\], which is within the range we identified in the *S. neurona* kinome in our study (i.e., 19 CMGCs; see [Table 1](#pathogens-06-00012-t001){ref-type="table"}). Notable of these were the two GSK homologs (SRCN_1731 and SRCN_1732). This finding is similar to what has been observed in *Plasmodium* parasites in which two GSK-3 enzymes have been reported, both of which are essential for the parasite \[[@B46-pathogens-06-00012]\]. Homology searches showed considerable sequence similarity (51% and 41% for SRCN_1731 and SRCN_1732, respectively) to the PfGSK-3 enzymes (data not shown). Notably, eight of the 19 CMGCs in *S. neurona* were CDKs, including CDK7 (SRCN_4674, SRCN_2759 and SRCN_761), CDK10 (SRCN_895) and CDK11 (SRCN_977). Available data show that CDKs are essential in *P. falciparum* \[[@B24-pathogens-06-00012]\]. We also identified two putative MAPK homologs (SRCN_4209 and SRCN_5365) and ERK7 (SRCN_6472) (see [Table 1](#pathogens-06-00012-t001){ref-type="table"}), a result that is comparable to the two MAPKs in the kinome of *P. falciparum* \[[@B17-pathogens-06-00012]\].

### 2.1.5. The OPK Group {#sec2dot1dot5-pathogens-06-00012}

The apicomplexan-specific OPKs are a tight cluster of PKs without clear relation to any of the other major PK groups. Notable of these are ROPKs, which have high sequence divergence and have been thought to be largely restricted to *T. gondii* \[[@B47-pathogens-06-00012]\], which has a total of 34 members spread in over 40 distinct sub-families \[[@B23-pathogens-06-00012]\]. Although their diversification in apicomplexans is poorly understood, some ROPKs are key virulence factors in *T. gondii* \[[@B23-pathogens-06-00012]\]. At least nine putative ROPKs could be identified in *S. neurona*, including ROPK19A (SRCN_6184), ROP27 (SRCN_3247), ROP30 (SRCN_2076), ROP33 (SRCN_7082 and SRCN_7086), ROP35 (SRCN_2183, SRCN_2123, SRCN_7083 and SRCN_4410) and ROP37 (SRCN_7084), implying that the ROPKs are not restricted to *T. gondii*. Although largely presumed to be inactive, ROPKs are implicated in the regulation of the host transcription \[[@B47-pathogens-06-00012]\], and their presence in *S. neurona* may support the hypothesis that the ROPKs have a unique activation mechanisms in their regulatory functions that facilitate apicomplexan pathogenesis \[[@B24-pathogens-06-00012],[@B48-pathogens-06-00012]\]. Other notable OPKs included two parasite-specific eukaryotic initiation factor-2 (elF2) kinases (elF2K-C (SRCN_1606) and elF2K-B (SRCN_4503)), four NEKs (SRCN_4528, SRCN_2630, SRCN_286 and SRCN_3151) and four ULKs (SRCN_3444, SRCN_3669, SRCN_6812 and SRCN_6157) ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). The elF2Ks are conserved in apicomplexans and are important for the induction of parasite differentiation into the bradyzoites cysts, which are clinically important \[[@B34-pathogens-06-00012]\].

### 2.1.6. The STE Group {#sec2dot1dot6-pathogens-06-00012}

The STEs are poorly represented in apicomplexans, and although most apicomplexans have one or two STE genes per genome, some parasites, such as *C. parvum*, are reported to harbor up to six STEs \[[@B17-pathogens-06-00012],[@B20-pathogens-06-00012]\]. Our results suggest that *S. neurona* has at least one putative STE ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). STEs are thought to function in MAPK pathway cascades despite the fact that this pathway is absent in apicomplexans. The small repertoire of apicomplexan STEs is in contrast to that reported in other parasites, such as trypanosomatids, in which these enzymes regulate the length of the flagella \[[@B49-pathogens-06-00012]\].

### 2.1.7. The TKL Group {#sec2dot1dot7-pathogens-06-00012}

Apicomplexans harbor a maximum of seven TKL-coding genes, which makes it notable that we identified six putative TKLs in *S. neurona* ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). Reverse genetics studies have demonstrated that some of the conserved TKLs, for instance PfTKL3, are essential for the asexual *Plasmodium* proliferation \[[@B27-pathogens-06-00012]\], thereby a potential drug target. Two of the six *S. neurona* putative TKLs had considerable sequence similarities to the *Plasmodium* TKLs, including SRCN_3466 (36% similar to *Plasmodiuim malariae* TKL1) and SCRN_1435 (49% similar to *Plasmodium ovale* TKL3) (data not shown).

### 2.1.8. The aPK Group {#sec2dot1dot8-pathogens-06-00012}

The aPKs have been detected in apicomplexan parasites, such as *P. falciparum* \[[@B17-pathogens-06-00012],[@B18-pathogens-06-00012]\] and *T. gondii*, which has at least four genes thought to encode these enzymes, the products of which are hypothesized to be part of the ovoid mitochondrial cytoplasmic (OMC) complex \[[@B50-pathogens-06-00012]\], a composite assembly of organelles observed only in growing tachyzoites of *T. gondii*. An exhaustive search of the *S. neurona* proteome revealed four putative PIKKs (SRCN_3988, SRCN_6464, SRCN_6465, SRCN_1259) and one PDHK (SRCN_1743) ([Table 1](#pathogens-06-00012-t001){ref-type="table"}). Whereas PIKKs have been identified in at least 12 apicomplexan kinomes, PDHK seem to have been identified only in the *T. gondii* kinome \[[@B17-pathogens-06-00012]\]. Our analyses of the putative *S. neurona* PKs did not yield any homologs of the Alpha and RIO kinases, implying that these PKs are absent from the kinome of this parasite; RIO kinases have been reported in *P. falciparum* \[[@B17-pathogens-06-00012],[@B18-pathogens-06-00012]\], as well as in the kinomes of other apicomplexans including *C. parvum*, *T. gondii* and *B. bovis* \[[@B17-pathogens-06-00012]\].

2.2. Evolution of S. neurona Protein Kinases {#sec2dot2-pathogens-06-00012}
--------------------------------------------

We investigated the evolutionary relationships among the various *S. neurona* PK groups and their homologs in related apicomplexans. Our analysis revealed valuable insights into the biology of these organisms. The kinome of *S. neurona* is comprised of slightly fewer AGCs (*n* = 9) compared to the kinomes of *T. gondii* (*n* = 11), *N. caninum* (*n* = 13) and *H. hammondi* (*n* = 15). In general, the phylogenetic clustering of the *S. neurona* AGCs mirrored the homologies of these enzymes to those of the three apicomplexans used in this study ([Figure 1](#pathogens-06-00012-f001){ref-type="fig"}; compare with [Table 1](#pathogens-06-00012-t001){ref-type="table"}). Sequence analysis of *S. neurona* AGCs revealed significant divergence with only \~30% sequence similarity amongst members of this group. Two *S. neurona* AGCs SRCN_5610 (SnPKA1) and SRCN_3990 (SnPKA2) clearly cluster with *T. gondii* PKAs TGME49_028420 and TGME49_015670 \[[@B51-pathogens-06-00012]\] ([Figure 1](#pathogens-06-00012-f001){ref-type="fig"}). Moreover, SRCN_5610 shares high (\~60%) full length sequence identity with its ortholog, TgPKA1. It is also notable that the single putative PKG (SRCN_4518) distinctly clustered with its *T. gondii* ortholog, TGME49_111360 (TgPKG) ([Figure 1](#pathogens-06-00012-f001){ref-type="fig"}). It has recently been shown that *P. falciparum* PKG acts as a signaling hub that plays a central role in a number of core parasite processes \[[@B52-pathogens-06-00012]\].

In addition to the kinase domain, SnPKA1, SRCN_3339, SRCN_5165 and SRCN_4518 possess the AGC-kinase C-terminal domain, which contains two of the three conserved phosphorylation sites in AGCs (data not shown). These conserved sites serve as phosphorylation-regulated switches in the control of both intra- and inter-molecular interactions \[[@B53-pathogens-06-00012]\]. Like *T. gondii*, *S. neurona* lacks PKB and PKC. However, *S. neurona* contains a putative phosphoinositide-dependent kinase-1, PDPK1 (SRCN_1312), that clusters with the *T. gondii* PDPK1 (TGME49_268210) \[[@B51-pathogens-06-00012]\].

Despite the absence of PKC in *S. neurona*, CAMK family members were identified, which perhaps underscores the importance of Ca^2+^ regulation in this apicomplexan parasite. The majority of the identified *S. neurona* CAMKs segregated with their orthologs in *T. gondii*, *N. caninum* and *H. hammondi* in clades with robust bootstraps ([Figure 2](#pathogens-06-00012-f002){ref-type="fig"}), thus validating the annotation of the CAMKs. Amongst the CAMKs, SRCN_2544 clustered with *T. gondii* PK1 (TGME049_243500) of the AMPK/SNF1 sub-family. There were also three additional SNF1 members in *S. neurona* (SRCN_5410, SRCN_4815 and SRCN_2257), which clustered with *T. gondii* TGME49_315190, TGME49_233905 and TGME49_291050, respectively.

Based on the clustering with *T. gondii* CDPK orthologs, 10 *S. neurona* CDPKs, including CDPK1 (SRCN_3314), CDPK2 (SRCN_4390), CDPK2A (SRCN_2165), CDPK3 (SRCN_3701), CDPK4 (SRCN_6606), CDPK5 (SRCN_3583), CDPK6 (SRCN_3011), CDPK7 (SRCN_6597), CDPK8 (SRCN_5948) and CDPK9 (SRCN_5812), were identified ([Figure 2](#pathogens-06-00012-f002){ref-type="fig"}). This result implies that *S. neurona* has potentially lost at least two CDPKs (compared to the 12 CDPK that have been reported in *T. gondii* \[[@B26-pathogens-06-00012]\]). The possible loss notwithstanding, *S. neurona* contained the six CDPKs that are expressed and are well-conserved in most apicomplexans (i.e., CDPK1, CDPK3, CDPK4, CDPK5, CDPK6 and CDPK7) \[[@B54-pathogens-06-00012]\]. Sequence analysis revealed that, like in other apicomplexans, all identified *S. neurona* CDPKs except SnCDPK7 contained both a kinase domain and a Ca^2+^-binding domain known as the EF-hand domain \[[@B26-pathogens-06-00012]\]. Like its *T. gondii* ortholog, TgCDPK7) SnCDPK7 contains a pleckstrin-homology (PH) domain just upstream of its PK domain \[[@B54-pathogens-06-00012]\]. The domain architecture in CDPKs is such that kinase activity is stimulated upon Ca^2+^-binding. Putative additional *S. neurona* CDPKs include SRCN_5227, which falls within the CDPK cluster and segregates with TGME49_040390 that is annotated as a CDPK and SRCN_4076 that clusters with TGME49_106480, also annotated as a CDPK ([Figure 2](#pathogens-06-00012-f002){ref-type="fig"}).

The majority of the putative CMGCs identified in *S. neurona* clustered with robust bootstrap support values with the conserved CMGCs in *T. gondii*, *N. caninum* and *H. hammondi* ([Figure 3](#pathogens-06-00012-f003){ref-type="fig"}). Based on the segregation of the CMGC kinases, four *S. neurona* CDK1 (SRCN_4801), CDK2 (SRCN_2759), CDK3 (SRCN_977) and CDK4 (SRCN_6346) were identified ([Figure 3](#pathogens-06-00012-f003){ref-type="fig"}). CDKs are amongst the main molecular switches that regulate cell cycle progression in apicomplexan parasites \[[@B55-pathogens-06-00012]\]. Additional *S. neurona* CMGC kinases identified include SRPK (SRCN_1236), CLK (SRCN_1479), PRP4 (SRCN_2845), DYRK (SRCN_1611), GSK-1A (SRCN_1731), GSK-1B (SRCN_1732), CK2 (SRCN_6427), ERK7 (SRCN_6472), MAPK-2 (SRCN_5365) and MAPK-1 (SRCN_4209), all of which fall in orthologous clades with robust bootstrap values. SRPK, CLK and PRP4 kinases most likely have crucial roles in parasite survival given their involvement in cycle-regulatory regulation \[[@B56-pathogens-06-00012],[@B57-pathogens-06-00012],[@B58-pathogens-06-00012]\], potentially via alternative mRNA splicing. Inhibition of PfCLK-mediated SR protein phosphorylation impaired blood stage replication and malaria transmission in *Plasmodium* \[[@B59-pathogens-06-00012]\]. The DYRK is implicated in a myriad of cell cycle functions that make this PK, hence an attractive drug target \[[@B60-pathogens-06-00012]\]. Other drug targets include MAPKs, which regulate diverse cellular functions, such as tissue morphogenesis, cytoskeletal rearrangements, proliferation, differentiation, survival, immune responses and adaptation/stress-responses \[[@B61-pathogens-06-00012]\]. The *S. neurona* putative MAPK-1 (SRCN_4209) ortholog in *T. gondii* (TgMAPK-1) is a virulence factor that alters IFN-γ-mediated control of *Toxoplasma* tachyzoite proliferation by manipulating IFN-γ-mediated nitric oxide synthase (iNOS) and NO generation \[[@B62-pathogens-06-00012]\].

In the OPK family, SRCN_4528, SRCN_2630 and SRCN_3151 are putative NEKs given their clustering with *T. gondii* NEK kinases TgNEK1 (TGME49_319700), TgNEK6 (TGME49_294260) and TgNEK5 (TGME49_018400), respectively ([Figure 4](#pathogens-06-00012-f004){ref-type="fig"}). *S. neurona* has two putative ULK kinases SRCN_108 (SnULK2) and SRCN_3444 (SnULK1) that cluster with their *T. gondii* orthologs TgULK1 (TGME49_235750) and TgULK2 (TGME49_240630), respectively). *S. neurona* contains three putative Aurora kinases; SRCN_2404 (SnAurora1-A), SRCN_2403 (SnAurora1-B) and SRCN_3417 (SnAurora2) that cluster with *T. gondii* aurora kinases, TgAurora1 (TGME49_118770) and TgAurora2 (TGME49_003010) ([Figure 4](#pathogens-06-00012-f004){ref-type="fig"}). *S. neurona* also contains a putative Wee kinase, SnWee (SRCN_286) that clusters with *T. gondii* Wee kinase, TgWee (TGME49_273690), as well as a NIMA kinase, SnNIMA1 (SRCN_5943), that clusters with TgNIMA1 (TGME49_292140). NIMA-related kinases are implicated in cell cycle control. Like its apicomplexan relatives *T. gondii* and *P. falciparum*, *S. neurona* contains tyrosine-kinase-like (TKL) kinase, SRCN_6572, that clusters with TGME49_234970. Moreover, *S. neurona* contains two elF2 kinases, SnIF2K-B (SRCN_4503) and SnIF2K-C (SRCN_1606) ([Figure 4](#pathogens-06-00012-f004){ref-type="fig"}). SRCN_4503 shows 74% sequence similarity to the *T. gondii* TgCatPRC2 \[IF2K-B\] ([Table 1](#pathogens-06-00012-t001){ref-type="table"}).

The clustering of putative *S. neurona* ROPKs was also notable. For instance, SRCN_7084 (SnROPK37) clustered with *T. gondii* TgROPK37 (TGME49_094560), implying that it is a ROPK37 ([Figure 4](#pathogens-06-00012-f004){ref-type="fig"}). SRCN_7082 and SRCN_4310 cluster with *T. gondii* TgROPK33 (TGME49_001130), suggesting that they are isoforms of ROPK33. Annotations in [Table 1](#pathogens-06-00012-t001){ref-type="table"} indicate that SRCN_4310 is a putative ROP33 (39% sequence similarity to *H. hammondi* ROP33). Moreover, SRCN_2183 (SnROPK35) clusters with TgROPK35 (TGME49_104740). Other putative *S. neurona* ROPKs include SRCN_7083 (SnROPK34A) and SRCN_4410 (SnROPK34B) that cluster with TgROP34 (TGME49_040090) ([Figure 4](#pathogens-06-00012-f004){ref-type="fig"}). SnROPK34A and SnROPK34B are potentially duplicated forms of TgROPK34.

Moreover, SRCN_3142 (SnPIK3R4) segregates with *T. gondii* TgPIK3R4 (TGME49_018550). NEKs are involved in cell cycle regulation, while Aurora kinases play pivotal roles in endodyogeny, duplication rate and parasite virulence \[[@B33-pathogens-06-00012]\]. Taken together, the presence of a variety of ROPKs in *S. neurona* is interesting given the fact that in *T. gondii*, ROPKs are key virulence factors \[[@B63-pathogens-06-00012]\].

3. Discussion {#sec3-pathogens-06-00012}
=============

The kinomes of apicomplexans range from 35 PKs (in *B. bovis*) to 135 PKs (in *T. gondii*) \[[@B24-pathogens-06-00012]\]. We identified a total of 97 putative PKs in the kinome of *S. neurona*, compared to the PKs reported in the kinomes of *P. falciparum* (*n* = 99), *T. gondii* (*n* = 135), *N. caninum* (*n* = 130) and *H. hammondi* (*n* = 124) \[[@B17-pathogens-06-00012],[@B19-pathogens-06-00012]\]. Although the total number of *S. neurona* PKs appeared markedly reduced compared to that of its close coccidian relatives (*T. gondii* and *N. caninum* \[[@B23-pathogens-06-00012]\]), taken as a percentage of total genome size, the proportion of *S. neurona* PKs is comparable to the 2% observed in humans \[[@B13-pathogens-06-00012]\] and other coccidians \[[@B23-pathogens-06-00012]\]. The contraction of the *S. neurona* kinome could be attributed to genome compaction, which occasionally offsets lineage-specific expansions of specific gene families. Notably, genome contraction is a common mode of genomic evolution in intracellular parasites, including apicomplexans \[[@B64-pathogens-06-00012],[@B65-pathogens-06-00012]\]. As such, the evolution of PKs may be in tandem to the overall genomic adaptive strategies of these parasites.

Using a hierarchical scheme based on the major PK groups, the *S. neurona* kinases could be classified and phylogenetically clustered into the various PK families. A complement of nine putative AGC kinases was identified in *S. neurona*, which is reduced compared with that of *T. gondii*, *N. caninum* and *H. hammondi*. Despite this potential gene loss, seven of the nine AGCs (SRCN_5165, SRCN_5610, SRCN_3339, SRCN_4249, SRCN_3990, SRCN_5430 and SRCN_1312) had orthologs in *T. gondii*, *N. caninum* and *H. hammondi*. In agreement with the observation that PKA is conserved in apicomplexans \[[@B23-pathogens-06-00012]\], two PKAs (SRCN_5610 and SRCN_3990) were identified in *S. neurona.* In *T. gondii*, increases in cytosolic cAMP levels activate PKA to trigger the developmental switch from the rapidly proliferating tachyzoites to the quiescent bradyzoites \[[@B66-pathogens-06-00012]\]. Additionally, two other *S. neurona* AGCs (SRCN_5165 and SRCN_3339) were putative PKAs given that they contained the characteristic *GxGxxG* motif found in PKA \[[@B51-pathogens-06-00012]\]. Notably, based on orthology, *S. neurona* contains a single putative PKG (SRCN_4518) that distinctly clustered with *T. gondii* PKG (TGME49_111360).

In apicomplexans, CAMKs modulate the intracellular Ca^2+^ concentration, which in turn regulates vital processes, such as host-cell invasion, protein secretion and parasite differentiation. We identified four potential AMPK/SNF1 family members (SRCN_2544, SRCN_5410, SRCN_4815 and SRCN_2257). The AMP-activated PK cascade acts as a metabolic sensor that monitors cellular AMP and ATP levels and is activated by an elevation of the AMP:ATP ratio. Further, we identified 12 putative CDPKs in the *S. neurona*, including CDPK1 (SRCN_3314), CDPK2 (SRCN_4390), CDPK2A (SRCN_2165), CDPK3 (SRCN_3701), CDPK4 (SRCN_6606), CDPK5 (SRCN_3583), CDPK6 (SRCN_3011), CDPK7 (SRCN_6597), CDPK8 (SRCN_5948), CDPK9 (SRCN_5812), SRCN_5227 and SRCN_4076. Compared to the 12 CDPKs reported in *T. gondii* \[[@B26-pathogens-06-00012]\], it appears that *S. neurona* had all six well-conserved apicomplexan CDPKs (CDPK1, CDPK3, CDPK4, CDPK5, CDPK6 and CDPK7), which provide a link between Ca^2+^ signaling and parasite differentiation, motility, invasion and egress \[[@B54-pathogens-06-00012]\]. In *T. gondii*, downregulation of CDPK1 interfered with parasite motility, host cell invasion and egress \[[@B43-pathogens-06-00012]\], while disruption of CDPK3 caused defective parasite egress \[[@B67-pathogens-06-00012]\]. Further, the essentiality of CDPK6 and CDPK7 in *T. gondii* has recently been demonstrated \[[@B68-pathogens-06-00012]\]. Indeed, TgCDPK1 has been targeted for the development of new drugs for toxoplasmosis \[[@B69-pathogens-06-00012]\]. Sequence analysis revealed that, similar to other apicomplexans, all identified *S. neurona* CDPKs except CDPK7 (SRCN_6597) contain both a PK domain and an EF-hand (Ca^2+^-binding) domain \[[@B26-pathogens-06-00012]\]. Similar to its *T. gondii* ortholog, TGME49_028750 (TgCDPK7), the *S. neurona* CDPK7 (SRCN_6597) contains a pleckstrin-homology (PH) domain just upstream of its PK domain \[[@B54-pathogens-06-00012]\]; the domain architecture is such that kinase activity is stimulated upon Ca^2+^ binding. Moreover, our phylogeny provided clues of possible gene duplications giving rise to SRCN_3990 and SRCN_3011, as well as SRCN_4093 and SRCN_1071. Interestingly, based on phylogenetic analysis, *S. neurona* probably contains four (SRCN_5227, SRCN_1071, SRCN_4093 and SRCN_3011) species-specific CAMKs.

The CMGCs, comprising CDKs, MAPKs, GSKs and CLKs, coordinate a wide range of cellular functions in different species. By both annotations and phylogenetic analyses, we identified four putative CDKs sub-family members; CDK5 (SRCN_4801 and SRCN_6346), CDK7 (SRCN_2759, SRCN_4674 and SRCN_761), CDK10 (SRCN_895) and CDK11 (SRCN_977). The finding of CDKs in *S. neurona* suggests that this parasite's cell cycle regulation could be CDK-dependent and perhaps similar to that of higher eukaryotes \[[@B70-pathogens-06-00012]\]. The identification of three putative MAPKs (SRCN_4209, SRCN_6472 and SRCN_5365) in *S. neurona* points to the existence of MAPK regulated transduction pathway(s) in this pathogen. Similar to its *T. gondii* ortholog (TgMAPK1), which is a p38α MAPK homolog \[[@B71-pathogens-06-00012]\], SRCN_4209 may be potentially involved in parasite proliferation/stage differentiation, stress response and manipulation of the host immunity to enhance virulence. On the other hand, SRCN_6472 and SRCN_5365 may augment the roles of SRCN_4209 in the parasite. In *T. gondii*, MAPK1/ERK7 is involved in intracellular proliferation \[[@B72-pathogens-06-00012]\]. We also identified two putative GSKs (SRCN_1731 and SRCN_1732). A genome-wide gene knockout approach in *P. falciparum* demonstrated PfGSK-3 to be critical for schizogony of the parasite \[[@B19-pathogens-06-00012]\]. Other *S. neurona* CMGC kinases identified include CLK (SRCN_1479), PRP4 (SRCN_2845), DYRK (SRCN_1611) CK2 (SRCN_6427) and SRPK (SRCN_1236).

ROPKs are secreted by *T. gondii* into the host cell and play roles in adhesion, motility and manipulation of immune responses \[[@B73-pathogens-06-00012]\]. We identified 11 putative ROPK sub-family members in the *S. neurona* kinome, i.e., ROPK37 (SRCN_7084), ROPK35 (SRCN_2183), ROPK33A (SRCN_7082), ROPK33B (SRCN_4310), ROPK34A (SRCN_7083), ROPK34B (SRCN_4410), SRCN_6184, SRCN_3216, SRCN_2076, SRCN_3247 and SRCN_2123. It has been recently demonstrated that *T. gondii* ROP21 and ROP27 play a role in a constitutive pathway based on their localization in the PV and cyst matrix \[[@B74-pathogens-06-00012]\]. However, the *S. neurona* putative ROPs 21 and 27 could not be clearly delineated in our clustering. Moreover, *T. gondii* ROP35 has been shown to play a crucial role in chronic infection \[[@B75-pathogens-06-00012]\]. Although the *S. neurona* genome is more than twice the size of other coccidians whose genomes were sequenced so far (e.g., *Toxoplasma* and *Neospora*), it has a considerably reduced number of ROPKs that nevertheless may have vital roles in the parasite's virulence. Specifically, *S. neurona* is devoid of ROP5, ROP16, ROP18 and ROP38, which have been shown to confer virulence and alter the host's cellular signaling pathways \[[@B72-pathogens-06-00012]\]. Putatively therefore, *S. neurona* ROPKs may have multiple roles in the survival of the parasite. In the search of drug targets against *S. neurona*, the reduced ROPKs with possible multiple roles and absent in the vertebrate host are thus attractive candidates.

4. Conclusions and Future Perspectives {#sec4-pathogens-06-00012}
======================================

The kinome of *S. neurona* contains members of the major classes of PKs, including AGC, CMGC, GSK, CAMK, CK, TKL, aPKs and several PKs in the OPK family. Similar to other apicomplexans, *S. neurona* kinome is devoid of PKC, the TKs, Alpha kinases, as well as RIO kinases. Further, the *S. neurona* kinome harbors two putative MAPK homologs, a finding that is similar to some apicomplexans, such as *P. falciparum*. *S. neurona* kinome also lacks some of the ROPKs that have been implicated in the virulence of *T. gondii*. Given the central roles played by PKs in the regulation of the host-parasite interactions and in the facilitation of the parasite proliferation and differentiation, delineation of the *S. neurona* kinome offers a platform for future development of efficacious drugs for EPM, for instance via parasite transmission blocking vaccine against the parasites (specific inhibition of the parasite's PKs). This approach is made possible by the differences between parasite and host PK homologs \[[@B76-pathogens-06-00012]\]. Zhang et al. \[[@B77-pathogens-06-00012]\] reviewed the applications and the progress made in the targeting of specific PKs as antimalarial drugs against *Plasmodium* parasites. Proof of principle of this approach has been demonstrated by the inhibition of human PKs using chemical ligands to treat cancers and other diseases \[[@B78-pathogens-06-00012],[@B79-pathogens-06-00012]\]. Recently, Ojo et al. \[[@B80-pathogens-06-00012]\] provided evidence that PKs can be targeted for rationally-designed drugs that can potently inhibit the growth of *S. neurona*. The technology is available and approved for therapeutic intervention, thus offering a unique prospect of repurposing chemical ligands to manage *S. neurona* infections \[[@B81-pathogens-06-00012]\]. It is however important to note that experimental validations are required to validate the *S. neurona* putative PKs to facilitate the development of anti-parasitic interventions. A potential approach is the application of genetically-encoded sensors to identify inhibitors of important parasite signaling pathways.

5. Materials and Methods {#sec5-pathogens-06-00012}
========================

5.1. Genome-Wide Identification of Putative S. neurona PKs {#sec5dot1-pathogens-06-00012}
----------------------------------------------------------

The predicted *S. neurona* proteome was downloaded from the Toxoplasma Genomics Resource database (Release 28; Version May 2016) \[[@B42-pathogens-06-00012]\]. A hidden Markov model (HMM) profile of signature PK domains obtained from the Kinomer database v 1.0 \[[@B82-pathogens-06-00012]\] was used to search for *S. neurona* kinases using HMMER v 3.1b2 \[[@B83-pathogens-06-00012]\]. The sequences having PK domain (IPR011009) or PK-like domain (IPR000719) were considered as putative kinases. Annotation of the putative kinase sequences was performed by BLASTp search against the non-redundant (nr)-NCBI protein and UniProtKB/Swiss-Prot databases at an *e*-value of ≤10^−6^. The identified *S. neurona* putative PKs were subsequently classified by BLASTp interrogations into the KinBase \[[@B84-pathogens-06-00012]\]. Gene ontology (GO) mapping was performed using Blast2GO v 4.0.7 \[[@B37-pathogens-06-00012]\]. The molecular weight (Mw) and isoelectric point (pI) were obtained using the ExPASy compute pI/Mw tool \[[@B85-pathogens-06-00012]\]. Motifs analysis was performed with the MEME Suite v 4.11.2 \[[@B86-pathogens-06-00012]\]. The parameters were as follows: number of repetitions, any; maximum numbers of motifs, 30; and the optimum motif widths, between 6 and 200 residues.

5.2. Phylogenetic Analysis {#sec5dot2-pathogens-06-00012}
--------------------------

Phylogenetic trees were constructed to decipher the orthologous and paralogous relationships of *S. neurona* kinases. Protein kinase domains from putative *S. neurona* kinase groups were extracted and aligned with protein kinase domains from their homologs in *T. gondii* \[[@B42-pathogens-06-00012]\], *H. hammondi* and *N. caninum* using MUSCLE \[[@B87-pathogens-06-00012]\]. The alignments were subsequently manually edited in Jalview \[[@B88-pathogens-06-00012]\] for curation of alignment to remove uncertain regions due to gaps and poor alignment. Phylogenetic reconstruction was undertaken using the maximum likelihood program PhyML 3.0 \[[@B89-pathogens-06-00012]\] and RAxML v 8.0 \[[@B90-pathogens-06-00012]\] and the Bayesian inference program MrBAYES v 3.2 \[[@B91-pathogens-06-00012]\]. For PhyML, the LG substitution model was selected assuming an estimated proportion of invariant sites and four gamma-distributed rate categories to account for rate heterogeneity across sites. The gamma shape parameter was estimated directly from the data. The robustness of internal branches was evaluated using 100 bootstraps. MrBayes was run for 5,000,000 generations with two runs and four chains in parallel and a burn-in of 25%. Obtained trees were rendered with the Interactive Tree of Life server (iTOL) \[[@B92-pathogens-06-00012]\].
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###### 

Description of the 97 putative protein kinases (PKs) identified in the kinome of *Sarcocystis neurona*. The putative PKs could be classified into eight groups. The amino acid coordinates of the conserved PK domains in the protein sequences and the PK homologies to other apicomplexan PKs are shown in Columns 7--12.

  Description of the Putative Protein Kinases (PKs) in the Genome of *S. neurona*                                                                     Description of Protein Kinase (PK) Homologies (BLASTp)                                                                                                                                                                                                                           
  --------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------------------- ------ ------- -------- ------------ ------------------------------------------------------------------------- ------ ----------------- ---- ----------------
  **1. Kinase Group AGC (Protein kinases A (PKA), G (PKG) and C (PKC) families)**                                                                                                                                                                                                                                                                                                                                                      
  SRCN_1312                                                                                                                                           AGC kinase                                                  3-phosphoinositide dependent PK-1 (PDK1)                                903    5.52    101.13   137--481     PDPK; (*T. gondii* RUB)                                                   417    6.00 × 10^−135^   59   KFG61374.1
  SRCN_3339                                                                                                                                           AGC kinase                                                  PKA                                                                     1428   8.85    147.52   1102--1417   Putative AGC kinase; (*N. caninum* L)                                     611    0.0               81   CEL65574.1
  SRCN_4249                                                                                                                                           AGC kinase                                                  Nuclear dbf2-related (NDR)                                              152    8.91    17.47    6--141       Putative AGC kinase; (*N. caninum* L)                                     219    2.00 × 10^−68^    76   XP_003883757.1
  SRCN_4518                                                                                                                                           PK G AGC kinase family member PKG                           Ciliate-E2                                                              425    5.83    48.78    97--399      AGC kinase TgPKG1; (*T. gondii* ME49)                                     830    0.0               92   EPR61116.1
  SRCN_3990                                                                                                                                           cAMP-dependent kinase                                       CAMKL; (MELK)                                                           1907   9.55    217.55   782--1634    cAMP-dependent protein kinase (*T. gondii* VEG)                           75.9   1 × 10^−12^       30   ESS31194.1
  SRCN_5165                                                                                                                                           cAMP-dependent PK, catalytic chain                          PKA                                                                     343    8.99    39.36    20--338      AGC kinase; (*T. gondii* ARI)                                             425    3.00 × 10^−150^   90   KYF43224.1
  SRCN_4913                                                                                                                                           Putative PK                                                 PKD                                                                     2330   6.42    244.64   1093--1737   Putative PK; (*E. tenella*)                                               107    9.00 × 10^−22^    60   XP_013228294.1
  SRCN_5430                                                                                                                                           AGC kinase                                                  Ribosomal protein S6 Kinases (RSK; (p70))                               1378   5.54    139.28   824--1344    AGC kinase; (*T. gondii* MAS)                                             223    3.00 × 10^−60^    59   KFH07588.1
  SRCN_5610                                                                                                                                           cAMP-dependent PK, catalytic chain                          PKA                                                                     333    9.00    37.96    12--318      cAMP-dependent PK, catalytic subunit; (*T. gondii* ME49)                  641    0.0               92   XP_002366464.1
  **2. Kinase Group calcium (Ca^2+^)-/calmodulin-regulated kinases (CAMK)**                                                                                                                                                                                                                                                                                                                                                            
  SRCN_1071                                                                                                                                           Ca^2+^-dependent kinase                                     CAMK1                                                                   1495   9.47    152.66   1085--1401   Putative PK; (*T. gondii* VEG)                                            188    1.00 × 10^−47^    67   ESS31884.1
  SRCN_2032                                                                                                                                           Putative PK                                                 Ciliate-C1                                                              297    6.22    33.26    15--297      PK; (*H. hammondi*)                                                       424    1.00 × 10^−146^   68   XP_008882026.1
  SRCN_2165                                                                                                                                           Ca^2+^-dependent kinase CDPK2B                              CDPK                                                                    692    7.33    75.65    101--401     Ca^2+^-dependent PK CDPK2A; (*T. gondii* ARI)                             674    0.0               90   KYF44522.1
  SRCN_2257                                                                                                                                           Histone kinase                                              CAMKL; (AMP-activated protein kinase (AMPK))                            1800   8.98    187.71   1159--1448   Putative CAM kinase, SNF1 family; (*E. acervulina*)                       377    7.00 × 10^−105^   64   XP_013252246.1
  SRCN_2544                                                                                                                                           CAM SNF1 AMK1 family                                        CAMKL;(AMPK-regulated kinase novel kinase (NUAK))                       333    5.71    37.85    62--333      CAM kinase, SNF1/AMK1 family ToxPK1; (*N. caninum* L)                     480    9.00 × 10^−167^   79   XP_003882065.1
  SRCN_2937                                                                                                                                           Ca^2+^-signaling kinase MARK                                CAMKL; (microtubule affinity regulating kinase (MARK))                  278    9.62    31.29    1--250       Putative Ca^2+^ signaling PK MARK; (*T. gondii* GT1)                      356    5.00 × 10^−124^   72   EPR59053.1
  SRCN_3011                                                                                                                                           Calmodulin-dependent PK (CAM) CDPK6                         CDPK                                                                    1435   9.25    154.44   1238--1435   Cdpk kinase domain; (*T. gondii*)                                         179    6.00 × 10^−49^    75   3IS5_A
  SRCN_3314                                                                                                                                           A Chain crystal Structure of TgCDPK1 with inhibitor bound   CDPK1                                                                   519    5.99    58.89    37--335      Calmodulin-domain PK 1; (*T. gondii*)                                     536    0.0               97   3MA6_A
  SRCN_3583                                                                                                                                           Ca^2+^-dependent kinase CDPK5                               CDPK                                                                    454    6.09    50.38    35--308      Ca^2+^-dependent PK CDPK5; (*T. gondii* ARI)                              776    0.0               89   KYF43137.1
  SRCN_3701                                                                                                                                           Ca^2+^-dependent kinase CDPK3                               CDPK                                                                    560    5.91    62.07    77--362      Ca^2+^-dependent Kinase; (*T. gondii*)                                    493    1.00 × 10^−172^   87   3DXN_A
  SRCN_4076                                                                                                                                           CAM CDPK family                                             CDPK                                                                    1701   5.93    181.42   1079--1663   CAM kinase, CDPK family; (*H. hammondi*)                                  239    2.00 × 10^−62^    69   XP_008884897.1
  SRCN_4093                                                                                                                                           PK                                                          CAMKL; (AMP-activated protein kinase (AMPK))                            1155   9.02    118.33   1--261       Putative atypical MEK-related kinase; (*N. caninum* L)                    222    1.00 × 10^−59^    70   XP_003880869.1
  SRCN_4390                                                                                                                                           Ca^2+^-dependent kinase CDPK2                               CDPK                                                                    790    6.24    85.47    280--556     Ca^2+^-dependent PK, related; (*N. caninum* L)                            1130   0.0               74   XP_003884321.1
  SRCN_4815                                                                                                                                           Histone kinase (partial)                                    CAMKL; (AMP-activated protein kinase (AMPK))                            711    6.53    75.98    1--314       SNF1-related PK catalytic-α KIN10, 5 AMP-activated PK; (*N. caninum* L)   568    0.0               48   CEL67550.1
  SRCN_5227                                                                                                                                           CAM CDPK CDPK8-like                                         CDPK                                                                    2748   8.98    282.12   796--885     Putative CAM kinase, CDPK family; (*N. caninum* L)                        117    3.00 × 10^−24^    59   XP_003881901.1
  SRCN_5410                                                                                                                                           Calmodulin-dependent PK (CAM-SNF1 family)                   CAMK1                                                                   467    8.94    52.04    168--446     CAM kinase, SNF1 family; (*H. hammondi*)                                  431    5.00 × 10^−134^   78   XP_008883430.1
  SRCN_5812                                                                                                                                           Ca^2+^-dependent kinase CDPK9                               CDPK                                                                    760    8.37    84.23    254--573     Ca^2+^-dependent PK CDPK9; (*H. hammondi*)                                1139   0.0               81   XP_008889286.1
  SRCN_5948                                                                                                                                           Ca^2+^-dependent kinase CDPK8                               CDPK                                                                    3298   7.11    345.85   208--860     EF-hand domain-containing protein; (*T. gondii* ME49)                     114    1.00 × 10^−23^    58   XP_002368547.1
  SRCN_6597                                                                                                                                           Ca^2+^ dependent kinase CDPK7                               CAMK1                                                                   1374   9.09    138.28   365--623     PK-PH domain-containing protein; (*T. gondii* ME49)                       813    0.0               80   XP_002366487.1
  SRCN_6606                                                                                                                                           Ca^2+^-dependent kinase CDPK4                               CDPK                                                                    1632   9.42    170.93   813--1236    Ca^2+^-dependent PK; (*T. gondii*)                                        731    0.0               58   CAD32376.2
  **3. Kinase Group casein kinase 1 (cell kinase 1)**                                                                                                                                                                                                                                                                                                                                                                                  
  SRCN_3445                                                                                                                                           Casein kinase I                                             CK1-D                                                                   323    9.34    37.65    6--290       Casein kinase 1; (*T. gondii* ME49)                                       603    0.0               94   XP_002366683.1
  SRCN_4587                                                                                                                                           Casein kinase I                                             CK1-D                                                                   137    7.78    15.94    1--137       Casein kinase I; (*H. hammondi*)                                          226    3.00 × 10^−71^    81   XP_008883809.1
  SRCN_4645                                                                                                                                           Casein kinase I                                             CK1-D                                                                   229    9.51    25.66    38--229      Casein kinase I; (*T. gondii* GAB2-2007-GAL-DOM2)                         259    1.00 × 10^−86^    79   KFG42638.1
  **4. Kinase Group CMGC (including cyclin-dependent kinases, mitogen-activated PKs, glycogen synthase kinases and CDK-like kinases)**                                                                                                                                                                                                                                                                                                 
  SRCN_1104                                                                                                                                           Cyclin-dependent kinase family 5                            Ca^2+^-dependent PK-L (CDKL)                                            372    9.23    42.71    1--318       Cyclin-dependent kinase family 5 protein; (*H. hammondi*)                 490    2.00 × 10^−173^   76   XP_008884207.1
  SRCN_1236                                                                                                                                           Cell-cycle-associated kinase (SRPK)                         Serine-arginine rich PK (SRPK)                                          2911   5.37    302.90   713--1837    PK; (*T. gondii* ME49)                                                    476    9.00 × 10^−141^   76   XP_002369401.1
  SRCN_1479                                                                                                                                           CMGC Lammer                                                 CLK                                                                     748    10.23   79.09    485--748     Cell-cycle-associated PK CLK; (*T. gondii* FOU)                           288    2.00 × 10^−81^    74   KFG33061.1
  SRCN_1611                                                                                                                                           CMGC Dual-specificity tyrosine-regulated kinase (DYRK)      DYRK; (DYRKP)                                                           1504   5.86    160.34   551--1498    Cell-cycle-associated PK DYRK; (*T. gondii* VEG)                          223    2.00 × 10^−57^    63   ESS33160.1
  SRCN_1731                                                                                                                                           Cell-cycle-associated kinase GSK                            Glycogen synthase kinase (GSK)                                          219    6.59    24.39    1--175       Cell-cycle-associated PK GSK; (*H. hammondi*)                             330    2.00 × 10^−112^   82   XP_008887193.1
  SRCN_1732                                                                                                                                           Cell-cycle-associated kinase GSK                            Glycogen synthase kinase (GSK)                                          203    10.78   20.72    86--203      CMGC kinase, GSK family TgPK3; (*E. brunetti*)                            114    1.00 × 10^−28^    91   CDJ46527.1
  SRCN_2759                                                                                                                                           Cell-cycle-associated kinase partial                        Ca^2+^-dependent PK (CDK); (CRK7)                                       1122   6.14    118.67   541--1122    Cell-cycle-associated PK CDK; (*T. gondii* VAND)                          118    1.00 × 10^−25^    79   KFH12036.1
  SRCN_2845                                                                                                                                           CMGC DYRK PRP4 kinase                                       DYRK; (PRP4)                                                            1665   9.76    177.08   1267--1596   Putative PK (CLK3); (*P. malariae*)                                       330    1.00 × 10^−102^   69   SBS85334.1
  SRCN_3891                                                                                                                                           CMGC kinase                                                 DYRK; (DYRK2)                                                           674    8.85    73.85    399--674     Putative CMGC kinase; (*T. gondii* ME49)                                  80.1   6.00 × 10^−14^    67   EPT25192.1
  SRCN_4209                                                                                                                                           CMGC MAPK family (ERK) MAPK-1                               Mitogen-activated PK (MAPK); (ERK))                                     2361   6.73    247.71   94--754      CMGC, MAPK/ (ERK) TgMAPK-1; (*E. brunetti*)                               137    1.00 × 10^−30^    74   CDJ49492.1
  SRCN_4674                                                                                                                                           Cyclin-dependent kinase                                     Ca^2+^-dependent PK (CDK); (CDK7)                                       138    7.80    15.50    1--138       Cyclin-dependent kinase; (*T. gondii* GT1)                                108    7.00 × 10^−27^    58   EPR60430.1
  SRCN_4801                                                                                                                                           Cell-cycle-associated kinase                                Ca^2+^-dependent PK (CDK); (CDK5)                                       300    6.08    34.33    1--289       CMGC kinase, CDK family TgPK2; (*N. caninum* L)                           576    0.0               91   XP_003885801.1
  SRCN_5365                                                                                                                                           Cell-cycle-associated kinase MAPK                           Mitogen-activated PK (MAPK; (ERK))                                      417    6.77    48.32    7--363       Cell-cycle-associated PK MAPK; (*H. hammondi*)                            823    0.0               93   XP_008886907.1
  SRCN_6346                                                                                                                                           Cell-cycle-associated kinase CDK                            Ca^2+^-dependent PK (CDK); (CDK5)                                       690    9.55    80.90    208--603     Putative cell-cycle-associated PK CDK; (*T. gondii* ARI)                  390    2.00 × 10^−122^   87   KYF45878.1
  SRCN_6427                                                                                                                                           CMGC CK2 kinase                                             Cell Kinase 2 (CK2)                                                     1395   10.29   144.86   885--1356    CMGC kinase, CK2 family; (*T. gondii* MAS)                                241    6.00 × 10^−73^    98   KFH07655.1
  SRCN_6472                                                                                                                                           Cell-cycle-associated kinase ERK7                           Mitogen-activated PK (MAPK; (ERK))                                      983    9.28    104.95   7--317       Cell-cycle-associated PK ERK7; (*T. gondii* ARI)                          647    0.0               81   KYF46268.1
  SRCN_761                                                                                                                                            Cell-cycle-associated kinase                                Ca^2+^-dependent PK (CDK); (CDK7)                                       577    9.34    58.39    144--490     Cell-cycle-associated PK; (*H. hammondi*)                                 283    3.00 × 10^−88^    68   XP_008882409.1
  SRCN_895                                                                                                                                            Cell-cycle-associated kinase                                Ca^2+^-dependent PK (CDK); (CDK10)                                      340    8.93    38.57    1--307       Cell-cycle-associated PK; (*T. gondii* ARI)                               234    6.00 × 10^−75^    76   KYF44017.1
  SRCN_977                                                                                                                                            Cell-cycle-associated kinase CDK                            Ca^2+^-dependent PK (CDK); (PITSLRE/CDK11)                              1502   7.38    156.35   1114--1429   Cell-cycle-associated PK CDK; (*T. gondii* p89)                           454    3.00 × 10^−135^   92   KFG28420.1
  **5. Kinase Group 'Other' (OPK; i.e., kinases with conventional PK (ePK) domains that do not fit into any of the other major groups of kinases)**                                                                                                                                                                                                                                                                                    
  SRCN_108                                                                                                                                            Unc-51-like autophagy activating kinase 1 (ULK1)            ULK                                                                     343    7.13    38.90    1-223        ULK kinase; (*T. gondii* VAND)                                            376    2.00 × 10^−130^   75   KFH07419.1
  SRCN_1606                                                                                                                                           eIF2 kinase IF2K-C                                          PEK; (general control nonderepressible 2 (GCN2))                        4034   8.98    406.57   1235--2178   eIF2 kinase IF2K-C; (*T. gondii* VAND)                                    259    4.00 × 10^−67^    35   KFH07289.1
  SRCN_2076                                                                                                                                           Rhoptry kinase family ROP30                                 Conserved hypothetical protein                                          1276   9.18    134.73   812--1260    ROP30 (*T. gondii* VEG)                                                   230    3.00 × 10^−63^    53   CEL76436.1
  SRCN_2123                                                                                                                                           Rhoptry kinase family ROP35                                 PLK; (PLK-Unclassified)                                                 291    9.30    33.50    53--265      ROP35; (*T. gondii* RUB)                                                  207    2.00 × 10^−61^    43   KFG59037.1
  SRCN_3216                                                                                                                                           Rhoptry kinase family ROP32                                 CAMK-Unique                                                             523    7.08    57.00    214--520     Putative PK; (*T. gondii* VAND)                                           167    1.00 × 10^−42^    30   KFH00232.1
  SRCN_2183                                                                                                                                           Rhoptry kinase family ROP35                                 Aurora-like                                                             226    6.36    25.84    1--212       ROP35; (*T. gondii* VEG)                                                  198    8.00 × 10^−59^    48   ESS33297.1
  SRCN_2271                                                                                                                                           Putative PK (incomplete catalytic triad)                    NimA (Never in mitosis gene A)-related Kinase (NEK)                     1463   9.02    157.18   437--1145    Putative PK; (*N. caninum* L)                                             327    5.00 × 10^−90^    68   XP_003881849.1
  SRCN_2403                                                                                                                                           Aurora kinase (incomplete catalytic triad)                  PLK; (SAK/Plk4)                                                         778    9.79    79.92    492--778     Putative Aurora kinase; (*N. caninum* L)                                  127    3.00 × 10^−28^    44   XP_003880644.1
  SRCN_2630                                                                                                                                           NimA related kinase (NEK) family protein                    NEK                                                                     351    8.70    38.38    1--336       NEK kinase; (*T. gondii* ME49)                                            242    8.00 × 10^−75^    52   XP_018638598.1
  SRCN_286                                                                                                                                            Wee kinase                                                  Inhibitory regulator of the *RAS*-cAMP (IRA1) kinase suppressor (IKS)   1019   6.20    106.67   598--959     Wee kinase; (*H. hammondi*)                                               445    5.00 × 10^−141^   58   XP_008882669.1
  SRCN_3075                                                                                                                                           Tyrosine kinase-like (TKL) protein                          Numb-associated kinase (NAK)                                            1571   8.41    164.18   16--500      TKL; (*T. gondii* TgCatPRC2)                                              138    1.00 × 10^−32^    73   KYK64203.1
  SRCN_3142                                                                                                                                           PIK3R4 kinase-related                                       Aurora                                                                  997    8.72    106.54   548--899     Putative PIK3R4 kinase-related protein; (*N. caninum* L)                  449    2.00 × 10^−137^   60   XP_003885774.1
  SRCN_3151                                                                                                                                           NimA related kinase (NEK) family protein                    NEK                                                                     3186   7.96    318.69   352--656     NEK kinase; (*T. gondii* VEG)                                             468    7.00 × 10^−131^   73   CEL78174.1
  SRCN_3247                                                                                                                                           Rhoptry kinase family ROP27                                 Ciliate-D                                                               345    8.94    38.81    23--325      ROP27; (*T. gondii* p89)                                                  163    4.00 × 10^−43^    31   KFG37427.1
  SRCN_3417                                                                                                                                           Aurora kinase                                               Aurora                                                                  438    7.65    48.49    14--289      Aurora kinase; (*T. gondii* TgCatPRC2)                                    490    3.00 × 10^−155^   76   KYK63669.1
  SRCN_3444                                                                                                                                           Unc-51-like Autophagy activating kinase 1 (ULK1)            ULK                                                                     406    6.52    44.69    12--406      ULK kinase; (*T. gondii* RUB)                                             232    3.00 × 10^−71^    61   KFG59767.1
  SRCN_3669                                                                                                                                           CMGC kinase                                                 ULK                                                                     1803   8.41    189.65   736--1200    Putative CMGC kinase; (*N. caninum* L)                                    624    0.0               62   CEL65030.1
  SRCN_4410                                                                                                                                           Rhoptry kinase family ROP35                                 PKA-like                                                                204    9.44    23.50    1--166       ROP35; (*H. hammondi*)                                                    107    1.00E × 10^−25^   39   XP_008885989.1
  SRCN_4503                                                                                                                                           eIF2 kinase IF2K-B                                          PEK; (general control nonderepressible 2 (GCN2))                        158    5.76    17.59    1--158       eIF2 kinase IF2K-B (*T. gondii* TgCatPRC2)                                149    5.00 × 10^−41^    74   KYK69938.1
  SRCN_4528                                                                                                                                           NimA related kinase (NEK) family protein                    NEK                                                                     187    8.20    21.23    1--186       NEK kinase; (*H. hammondi*)                                               177    4.00 × 10^−54^    64   XP_008885186.1
  SRCN_2404                                                                                                                                           Aurora kinase (incomplete catalytic triad)                  Serum and glucocorticoid induced Kinase (SGK)                           295    8.81    31.42    1--249       Putative Aurora kinase; (*N. caninum* L)                                  126    7.00 × 10^−31^    43   CEL65223.1
  SRCN_5653                                                                                                                                           PEK kinase                                                  Aurora                                                                  626    8.27    60.75    513--626     PEK kinase (*T. gondii* TgCatPRC2)                                        251    1.00 × 10^−76^    60   KYK62422.1
  SRCN_5943                                                                                                                                           NIMA-related kinase NIMA1                                   NEK                                                                     2842   9.04    295.44   73--383      NIMA-related PK NIMA1; (*T. gondii* MAS)                                  486    2.00 × 10^−140^   67   KFH05809.1
  SRCN_6157                                                                                                                                           Unc-51-like autophagy activating kinase 1 (ULK1)            ULK                                                                     2420   9.38    250.58   1380--1672   ULK kinase (*T. gondii* ME49)                                             99.8   3 × 10^−21^       38   XP_018635814.1
  SRCN_6184                                                                                                                                           Myosin-light-chain kinase                                   Ciliate-E2-Unclassified                                                 478    5.42    53.65    177--474     ROP19A (*T. gondii ME49*)                                                 127    3.00 × 10^−30^    27   XP_018637476.1
  SRCN_6572                                                                                                                                           Tyrosine kinase-like (TKL)                                  ULK                                                                     622    6.13    68.80    1--345       TKL; (*T. gondii* VAND)                                                   181    1.00 × 10^−46^    74   KFH00338.1
  SRCN_6812                                                                                                                                           PK                                                          ULK                                                                     199    6.74    22.72    1--183       PK; (*H. hammondi*)                                                       172    3.00 × 10^−48^    53   XP_008887491.1
  SRCN_7083                                                                                                                                           Rhoptry kinase family ROP35                                 PKA-like                                                                262    9.62    30.26    1--242       ROP35; (*H. hammondi*)                                                    127    6.00 × 10^−32^    39   XP_008885989.1
  SRCN_4310                                                                                                                                           Rhoptry kinase family ROP33                                 Kinase Homologous to SPS1/STE20 (KHS)                                   1591   9.85    169.63   1265--1578   ROP33; (*H. hammondi*)                                                    306    2.00 × 10^−87^    39   XP_008887632.1
  SRCN_7082                                                                                                                                           Rhoptry kinase family ROP33                                 Kinase Homologous to SPS1/STE20 (KHS)                                   403    9.59    45.92    77--390      ROP33 (*T. gondii* p89)                                                   277    3.00 × 10^−89^    40   KFG45248.1
  SRCN_7084                                                                                                                                           Rhoptry kinase family ROP37                                 Ribosomal protein S6 Kinases (RSK; (RSK))                               339    5.41    38.09    19--334      ROP37; (*N. caninum* L)                                                   144    1.00 × 10^−36^    36   CEL64242.1
  **6. Kinase Group "Sterile" serine/threonine kinase, or sterile-phenotype kinases (STE)**                                                                                                                                                                                                                                                                                                                                            
  SRCN_1328                                                                                                                                           Serine threonine kinase                                     Conserved hypothetical protein                                          1461   9.29    158.74   559--671     Hypothetical protein, conserved; (*E. maxima*)                            88.6   5.00 × 10^−16^    68   XP_013335801.1
  SRCN_5172                                                                                                                                           "Sterile" serine/threonine kinase (STE)                     Mammalian Sterile 20-like (MST))                                        6552   6.14    671.51   3410--4122   STE kinase; (*T. gondii* TgCatPRC2)                                       412    1.00 × 10^−114^   54   KYK71951.1
  **7. Kinase Group Tyrosine Kinase-Like (TKL)**                                                                                                                                                                                                                                                                                                                                                                                       
  SRCN_1435                                                                                                                                           Tyrosine kinase-like (TKL)                                  Mixed lineage kinase (MLK); (Leucine Zipper-bearing Kinase (LZK))       3064   8.05    306.74   2540--3060   Tyrosine kinase-like (TKL) protein; (*N. caninum* L)                      278    3.00 × 10^−73^    72   CEL64955.1
  SRCN_1571                                                                                                                                           Tyrosine kinase-like (TKL)                                  Microtubule-associated S/T kinase (MAST)                                550    9.76    59.91    135--501     Conserved hypothetical protein; (*E. praecox*)                            76.3   6.00 × 10^−13^    53   CDI87140.1
  SRCN_3466                                                                                                                                           Tyrosine kinase-like (TKL)                                  TKL-Unique                                                              3002   9.87    320.97   2342--2997   Tyrosine kinase-like (TKL) protein; (*H. hammondi*)                       202    3.00 × 10^−50^    65   XP_008887506.1
  SRCN_3928                                                                                                                                           Tyrosine kinase-like (TKL)                                  LISK - LIMK (LIM kinase) and TESK (Testicular protein Kinase); (DD1)    5842   8.78    608.80   3639--4268   Tyrosine kinase-like (TKL) protein; (*T. gondii* TgCatPRC2)               216    2.00 × 10^−61^    79   KYK63216.1
  SRCN_4277                                                                                                                                           Kinase domain-containing protein                            TKL-ciliate1                                                            2256   8.43    240.25   1570--2256   Tyrosine kinase-like (TKL) protein; (*N. caninum* L)                      204    8.00 × 10^−51^    61   CEL67693.1
  SRCN_811                                                                                                                                            Tyrosine kinase-like (TKL)                                  TKL-Unique                                                              1099   9.18    119.26   814--1083    Putative tyrosine kinase-like (TKL) protein; (*E. acervulina*)            403    6.00 × 10^−125^   59   XP_013252162.1
  **8. Kinase Group Atypical (aPKs)**                                                                                                                                                                                                                                                                                                                                                                                                  
  SRCN_3601                                                                                                                                           Atypical MEK-related kinase                                 Muscle-associated kinase TRIO                                           950    7.20    103.14   381--850     Atypical MEK-related kinase; (*T. gondii* GT1)                            171    1.00 × 10^−42^    32   EPR62774.1
  SRCN_5962                                                                                                                                           Atypical MEK-related kinase                                 Rho-associated protein kinase (ROCK)-like                               805    5.01    87.71    525--805     Atypical MEK-related kinase; (*H. hammondi*)                              127    4.00 × 10^−29^    56   XP_008884362.1
  SRCN_3988                                                                                                                                           Phosphatidylinositol 3-/4-kinase (PI3K)                     Atypical/PIKK/ATM                                                       4251   5.95    440.5    3671--3772   PI3K, ; (*H. hammondi*)                                                   268    1 × 10^−69^       55   XP_008886631.1
  SRCN_6465                                                                                                                                           Phosphatidylinositol 3-/4-kinase (PI3K)                     Atypical PIKK/ATM                                                       207    5.2     23.24    5-122        Phosphatidylinositol 4-kinase, partial; (*T. gondii* p89)                 272    4 × 10^−93^       96   KFG28404.1
  SRCN_1259                                                                                                                                           Phosphatidylinositol 3-/4-kinase (PI3K)                     Atypical/PIKK/FRAP                                                      1362   9.56    142.85   1140--1311   PI3K; (*T. gondii* MAS)                                                   317    3 × 10^−94^       76   KFH10008.1
  SRCN_6464                                                                                                                                           Phosphatidylinositol 3-/4-kinase (PI3K)                     No hits found                                                           2108   8.95    209.68   1626--1722   Phosphatidylinositol 3-4-kinase; (*T. gondii* p89)                        244    1 × 10^−63^       66   KFG28409.1
  SRCN_1743                                                                                                                                           Pyruvate dehydrogenase kinase                               Atypical/PDHK/BCKDK                                                     930    6.50    101.41   291--426     PDHK, isoenzyme-2; (*N. caninum* L)                                       458    6 × 10^−146^      45   CEL70411.1

^a^ The protein sequences and their corresponding identified were obtained from the Toxoplasma Genomics Resource database (Release 28; Version May 2016) \[[@B42-pathogens-06-00012]\]; ^b^ the descriptions of the protein sequence are based on BLASTp annotations using Blast2GO (see the text for details); ^c^ the kinase classification is based on BLASTp on the kinase database.
